LIXT logo

LIXT Cash From Financing

Annual CFF

$3.14 M
-$2.00 M-38.86%

December 31, 2023

Summary

Performance

1-Year Change

-38.86%

3-Year Change

-31.69%

5-Year Change

-29.81%

15-Year Change

+24.84%

LIXT Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.4%
LIXT annual cash flow from financing activities is higher than 43.4% of companies in Healthcare sector

High & Low

All-time High

$5.14 M
LIXT annual cash flow from financing activities is currently -38.86% below its historical high of $5.14 million

3-Year Low

$3.14 M
LIXT annual cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
LIXT previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 9, 2025
LIXT next annual earnings announcement is scheduled for May 9, 2025

OtherLIXTcash flowmetrics:

Annual CFI

-
LIXT annual cash flow from investing activities value is unknown

Annual CFO

-$4.29 M
LIXT annual cash flow from operations is -$4.29 million

Annual FCF

-$4.29 M
LIXT annual free cash flow is -$4.29 million

Annual CAPEX

-
LIXT annual capital expenditures value is unknown

Quarterly CFF

$0.00
$0.000.00%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

LIXT Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.16%
LIXT quarterly cash flow from financing activities is higher than 45.16% of companies in Healthcare sector

High & Low

All-time High

$5.15 M
LIXT quarterly cash flow from financing activities is currently -100.00% below its historical high of $5.15 million

3-Year Low

-$10.90 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
LIXT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 9, 2025
LIXT next earnings announcement is scheduled for May 9, 2025

OtherLIXTcash flowmetrics:

Quarterly CFI

-
LIXT quarterly cash flow from investing activities value is unknown

Quarterly CFO

-$957.60 K
LIXT quarterly cash flow from operations is -$957.60 thousand

Quarterly FCF

-$957.60 K
LIXT quarterly free cash flow is -$957.60 thousand

Quarterly CAPEX

-
LIXT quarterly capital expenditures value is unknown

TTM CFF

$0.00
-$3.14 M-100.00%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

LIXT TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

25.99%
LIXT TTM cash flow from financing activities is higher than 25.99% of companies in Healthcare sector

High & Low

All-time High

$8.62 M
LIXT TTM cash flow from financing activities is currently -100.00% below its historical high of $8.62 million

3-Year Low

$0.00
LIXT TTM cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
LIXT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

May 9, 2025
LIXT next earnings announcement is scheduled for May 9, 2025

OtherLIXTcash flowmetrics:

TTM CFI

-
LIXT TTM cash flow from investing activities value is unknown

TTM CFO

-$3.47 M
LIXT TTM cash flow from operations is -$3.47 million

TTM FCF

-$3.47 M
LIXT TTM free cash flow is -$3.47 million

TTM CAPEX

-
LIXT TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

LIXT Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-38.9%0.0%0.0%
3 y3 years-31.7%0.0%0.0%
5 y5 years-29.8%0.0%0.0%

LIXT Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-38.9%at low-100.0%+100.0%-100.0%at low
5 y5-year-38.9%-100.0%-100.0%+100.0%-100.0%+100.0%
alltimeall time-38.9%-100.0%-100.0%+100.0%-100.0%+100.0%

Lixte Biotechnology Holdings Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$0.00(0.0%)
$0.00(-100.0%)
Jun 2024
-
$0.00(0.0%)
$3.14 M(0.0%)
Mar 2024
-
$0.00(0.0%)
$3.14 M(-0.2%)
Dec 2023
$3.14 M(-38.9%)
$0.00(-100.0%)
$3.14 M(0.0%)
Sep 2023
-
$3.14 M(>+9900.0%)
$3.14 M(>+9900.0%)
Jun 2023
-
$0.00(-100.0%)
$6300.00(-99.9%)
Mar 2023
-
$6300.00(>+9900.0%)
$5.16 M(+0.3%)
Dec 2022
$5.14 M(+31.9%)
$0.00(0.0%)
$5.14 M(-0.2%)
Sep 2022
-
$0.00(-100.0%)
$5.15 M(-1.7%)
Jun 2022
-
$5.15 M(<-9900.0%)
$5.24 M(+2657.2%)
Mar 2022
-
-$10.90 K(-209.0%)
$190.10 K(-95.1%)
Dec 2021
$3.90 M(-15.3%)
$10.00 K(-88.9%)
$3.90 M(-54.8%)
Sep 2021
-
$90.00 K(-10.9%)
$8.62 M(+1.9%)
Jun 2021
-
$101.00 K(-97.3%)
$8.46 M(+1.9%)
Mar 2021
-
$3.70 M(-21.9%)
$8.30 M(+80.3%)
Dec 2020
$4.60 M(>+9900.0%)
$4.73 M(-6460.3%)
$4.60 M(-3634.5%)
Sep 2020
-
-$74.40 K(+33.3%)
-$130.20 K(+133.3%)
Jun 2020
-
-$55.80 K(<-9900.0%)
-$55.80 K(<-9900.0%)
Mar 2020
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2019
$0.00(-100.0%)
$0.00(0.0%)
$0.00(-100.0%)
Sep 2019
-
$0.00(0.0%)
$4.48 M(-0.1%)
Jun 2019
-
$0.00(-100.0%)
$4.48 M(0.0%)
Dec 2018
$4.48 M(+77.9%)
$4.48 M(>+9900.0%)
$4.48 M(>+9900.0%)
Sep 2018
-
$3000.00(>+9900.0%)
$3000.00(-99.9%)
Dec 2017
$2.52 M(+44.1%)
$0.00(-100.0%)
$2.52 M(0.0%)
Sep 2017
-
$18.00 K(-98.8%)
$2.52 M(+0.7%)
Jun 2017
-
$1.50 M(+50.0%)
$2.50 M(+58.1%)
Mar 2017
-
$1.00 M(>+9900.0%)
$1.58 M(-9.5%)
Dec 2016
$1.75 M(-14.8%)
$0.00(0.0%)
$1.75 M(0.0%)
Sep 2016
-
$0.00(-100.0%)
$1.75 M(0.0%)
Jun 2016
-
$581.30 K(-50.2%)
$1.75 M(+18.0%)
Mar 2016
-
$1.17 M(>+9900.0%)
$1.48 M(-27.8%)
Dec 2015
$2.05 M(+45.3%)
$0.00(0.0%)
$2.05 M(0.0%)
Sep 2015
-
$0.00(-100.0%)
$2.05 M(0.0%)
Jun 2015
-
$315.00 K(-81.9%)
$2.05 M(-34.8%)
Mar 2015
-
$1.74 M(>+9900.0%)
$3.15 M(+123.0%)
DateAnnualQuarterlyTTM
Dec 2014
$1.41 M(>+9900.0%)
$0.00(0.0%)
$1.41 M(0.0%)
Sep 2014
-
$0.00(-100.0%)
$1.41 M(0.0%)
Jun 2014
-
$1.41 M(>+9900.0%)
$1.41 M(>+9900.0%)
Mar 2014
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2013
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2013
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2013
-
$0.00(0.0%)
$0.00(-100.0%)
Mar 2013
-
$0.00(0.0%)
$2.47 M(-1.3%)
Dec 2012
$2.50 M(>+9900.0%)
$0.00(0.0%)
$2.50 M(0.0%)
Sep 2012
-
$0.00(-100.0%)
$2.50 M(0.0%)
Jun 2012
-
$2.47 M(+7312.0%)
$2.50 M(+6431.3%)
Mar 2012
-
$33.30 K(>+9900.0%)
$38.30 K(+666.0%)
Dec 2011
$5000.00(-99.5%)
$0.00(0.0%)
$5000.00(0.0%)
Sep 2011
-
$0.00(-100.0%)
$5000.00(0.0%)
Jun 2011
-
$5000.00(>+9900.0%)
$5000.00(>+9900.0%)
Mar 2011
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2010
$1.09 M(-50.5%)
$0.00(0.0%)
$1.09 M(-59.5%)
Sep 2010
-
$0.00(0.0%)
$2.69 M(-3.6%)
Jun 2010
-
$0.00(-100.0%)
$2.79 M(-7.2%)
Mar 2010
-
$1.09 M(-32.0%)
$3.00 M(+36.6%)
Dec 2009
$2.20 M(+2097.0%)
$1.60 M(+1500.0%)
$2.20 M(+215.2%)
Sep 2009
-
$100.00 K(-53.4%)
$697.10 K(+16.7%)
Jun 2009
-
$214.80 K(-23.9%)
$597.10 K(+56.2%)
Mar 2009
-
$282.30 K(+182.3%)
$382.30 K(+282.3%)
Dec 2008
$100.00 K(-81.2%)
$100.00 K(>+9900.0%)
$100.00 K(-81.2%)
Sep 2008
-
$0.00(0.0%)
$531.60 K(0.0%)
Jun 2008
-
$0.00(0.0%)
$531.60 K(0.0%)
Mar 2008
-
$0.00(-100.0%)
$531.60 K(0.0%)
Dec 2007
$531.60 K(-52.5%)
$531.60 K(>+9900.0%)
$531.60 K(+2773.5%)
Sep 2007
-
$0.00(0.0%)
$18.50 K(-95.9%)
Jun 2007
-
$0.00(0.0%)
$446.40 K(-57.4%)
Mar 2007
-
$0.00(-100.0%)
$1.05 M(-6.3%)
Dec 2006
$1.12 M(+2882.9%)
$18.50 K(-95.7%)
$1.12 M(+1.7%)
Sep 2006
-
$427.90 K(-28.9%)
$1.10 M(+63.7%)
Jun 2006
-
$601.70 K(+753.5%)
$672.20 K(+853.5%)
Mar 2006
-
$70.50 K
$70.50 K
Dec 2005
$37.50 K
-
-

FAQ

  • What is Lixte Biotechnology Holdings annual cash flow from financing activities?
  • What is the all time high annual CFF for Lixte Biotechnology Holdings?
  • What is Lixte Biotechnology Holdings annual CFF year-on-year change?
  • What is Lixte Biotechnology Holdings quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Lixte Biotechnology Holdings?
  • What is Lixte Biotechnology Holdings quarterly CFF year-on-year change?
  • What is Lixte Biotechnology Holdings TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Lixte Biotechnology Holdings?
  • What is Lixte Biotechnology Holdings TTM CFF year-on-year change?

What is Lixte Biotechnology Holdings annual cash flow from financing activities?

The current annual CFF of LIXT is $3.14 M

What is the all time high annual CFF for Lixte Biotechnology Holdings?

Lixte Biotechnology Holdings all-time high annual cash flow from financing activities is $5.14 M

What is Lixte Biotechnology Holdings annual CFF year-on-year change?

Over the past year, LIXT annual cash flow from financing activities has changed by -$2.00 M (-38.86%)

What is Lixte Biotechnology Holdings quarterly cash flow from financing activities?

The current quarterly CFF of LIXT is $0.00

What is the all time high quarterly CFF for Lixte Biotechnology Holdings?

Lixte Biotechnology Holdings all-time high quarterly cash flow from financing activities is $5.15 M

What is Lixte Biotechnology Holdings quarterly CFF year-on-year change?

Over the past year, LIXT quarterly cash flow from financing activities has changed by $0.00 (0.00%)

What is Lixte Biotechnology Holdings TTM cash flow from financing activities?

The current TTM CFF of LIXT is $0.00

What is the all time high TTM CFF for Lixte Biotechnology Holdings?

Lixte Biotechnology Holdings all-time high TTM cash flow from financing activities is $8.62 M

What is Lixte Biotechnology Holdings TTM CFF year-on-year change?

Over the past year, LIXT TTM cash flow from financing activities has changed by $0.00 (0.00%)